ea0029p719 | Diabetes | ICEECE2012
Saraiva J.
, Carrilho F.
, Barros L.
, Batista C.
, Melo M.
, Gomes L.
, Vieira A.
, Alves M.
, Gouveia S.
, Moreno C.
, Carvalheiro M.
Background: Continuous subcutaneous insulin infusion (CSII) using an external pump is an alternative intensive diabetes therapy recognized to improve metabolic control and glycemic instability in selected type 1 diabetic (T1DM) subjects. The aim of this study was to examine the clinical effectiveness and safety of CSII systems over a 5-year follow-up period in T1DM patients.Materials and methods: We performed a retrospective observational study of T1DM p...